Latest News

The innovative medical approach of immunotherapy, harnessing the body's immune system to fight diseases like cancer more effectively. Abstract concept. | Image Credit: © TensorSpark - © TensorSpark - stock.adobe.com
Cancer Research UK Partners with Nxera on Next-Stage Trial for HTL0039732

September 17th 2025

The Phase IIa study will test HTL0039732 in combination with immunotherapy to boost responses in resistant solid tumors and broaden treatment choices.

Close up shot pharmacist holding nasal spray medicine at the drugstore.Seasonal health issues | Image Credit: © I Viewfinder - stock.adobe.com
FDA Approves Cortasis Nasal Spray, Enbumyst, for Edema

September 16th 2025

Digital composite of highlighted red painful liver of woman | Image credit: ©mi_viri -stock.adobe.com
Competition in MASH is Heating Up as GLP-1s Gate-Crash the Party

September 15th 2025

Image Credit: © Patrick Lavery - MJH Life Sciences
CPHI Frankfurt Expected to Draw More Than 60,000 Attendees in October

September 12th 2025

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
Medicines Discovery Catapult and Crown Bioscience Create Alliance for Radiopharmaceuticals

September 12th 2025

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Research into Cold Cancers Heating Up; Image: catalin - Stock.adobe.com

More News

© 2025 MJH Life Sciences

All rights reserved.